We are live on ! Find out more
CRDF icon

Cardiff Oncology

55 hedge funds and large institutions have $11.6M invested in Cardiff Oncology in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 7

1.38% less ownership

Funds ownership: 17.16% → 15.78% (-1.4%)

5% less funds holding

Funds holding: 58 → 55 (-3)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

26% less capital inflows, than outflows

Capital inflows: $1.87M | Capital outflows: $2.52M

85% less call options, than puts

Call options by funds: $37K | Put options by funds: $251K

Holders
55
Holders Change
-3
Holders Change %
-5.17%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
16
Reduced
7
Closed
8
Calls
$37​K
Puts
$251​K
Net Calls
-⁠$214​K
Net Calls Change
-⁠$144​K

CRDF Hedge Fund Activity: Q1 2023 in Review

55 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2023, worth a combined $11.6M — up 8.4% from $10.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of CRDF and 6 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 16 added.

The largest buyer was Citigroup, adding an estimated $1.12M. The largest seller was Artal Group, exiting entirely with an estimated $1.05M sold.

  • 55 institutional investors held Cardiff Oncology (CRDF) as of Q1 2023, down from 58 in Q4 2022.
  • Funds reported $11.6M of Cardiff Oncology stock for Q1 2023, up 8.4% quarter-over-quarter.
  • 6 funds opened new Cardiff Oncology positions in Q1 2023 and 8 closed out, a net change of -2 holders.
  • The largest Cardiff Oncology buyer in Q1 2023 was Citigroup, an estimated $1.12M added.
  • The largest Cardiff Oncology seller in Q1 2023 was Artal Group, an estimated $1.05M sold.

Based on aggregated 13F filings for Q1 2023.